INI SS July 2024: Seat matrix Revised For 4 specialities at JIPMER, AIIMS Jodhpur, Check Details

Published On 2024-05-03 07:29 GMT   |   Update On 2024-05-03 07:29 GMT

New Delhi- The seat matrix for the Institutes of National Importance Super-Speciality Entrance Examination (AIIMS INI-SS) for admission to DM, MCh and MD (Hospital Administration) courses has been revised again for the July 2024 session.

“As per communication received seats stand revised for INI-SS July 2024 Session”, the official notice stated and according to the revised seat list, seats have been revised in total 3 courses in JIPMER and 1 in AIIMS Jodhpur. 

Advertisement

SEAT MATRIX

S.NO

SUBJECT

INSTITUTE

EARLIER SEATS

REVISED SEATS

1

DM-Nephrology.

JIPMER

General

SPONSORED

Foreign National

General

SPONSORED

Foreign National

0

2

0

1

2

0

2

DM-Neurology.

JIPMER

0

1

0

1

1

0

3

DM-Neuro-Anesthesiology & Neurocritical Care.

JIPMER

0

0

0

1

0

0

4

DM- Endocrinology.

AIIMS Jodhpur

2

1

0

0

1

0

To view the notice, click the link below

Students are requested to visit the official website of the AIIMS Exam for guidelines, number of seats, eligibility criteria, detailed information etc. Also, applicants are required to visit the website regularly as all subsequent corrigendum/addendum/updates will be uploaded on the website only, the notice lastly added.

INI-SS for July 2024 session is planned to be held in 16 cities in India such as Ahmedabad, Puducherry, Bhopal, Bhopal. It is been conducted for the admission to DM, MCh and MD (Hospital Administration) courses in AIIMS, PGIMER, NIMHANS, SCTIMST and JIPMER for the July 2024 session. The course will resume from 01 July 2024.

The registration process for the said course has been closed at 5:00 PM on Wednesday, 10th April 2024. Meanwhile, only the last two processes i.e. admission to the course and fulfillment of eligibility for admission are left which will take place on 31st July 2024 and 31st August 2024.

Tags:    

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News